v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Cash flows from operating activities:            
Net loss   $ (369) $ (4,306) $ (1,586) $ (5,867)  
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:            
Depreciation and amortization       1,775 1,408  
Impairment of property and equipment   361   361    
Stock-based compensation       1,075 75  
Amortization of debt issuance costs         84  
Remeasurement of convertible preferred stock warrant liability     3,725   3,725  
Changes in operating assets and liabilities:            
Accounts receivable and unbilled revenue       (2,431) (666)  
Prepaid expenses and other assets       (568) (201)  
Accounts payable       1,105 (307)  
Accrued expenses and other current liabilities       (701) (216)  
Deferred revenue       134 3,049  
Net cash provided by (used in) operating activities       (836) 1,084  
Cash flows from investing activities:            
Purchase of property and equipment       (5,643) (2,870)  
Investment in intangible and other assets       (26) (24)  
Net cash used in investing activities       (5,669) (2,894)  
Cash flows from financing activities:            
Proceeds from initial public offering, net of commissions and discounts $ 32,400       32,426  
Proceeds from notes payable         1,500  
Payment of debt issuance costs         (30)  
Payments of offering costs         (846)  
Proceeds from exercise of stock options       450 10  
Proceeds from exercise of warrants       989    
Proceeds from Employee Stock Purchase Plan       421    
Net cash provided by financing activities       1,860 33,060  
Increase (decrease) in cash and cash equivalents       (4,645) 31,250  
Effect of exchange rate on cash and cash equivalents       (81) 5  
Cash, cash equivalents and restricted cash at beginning of year       19,597 3,895 $ 3,895
Cash, cash equivalents and restricted cash at end of period 35,150 $ 14,871 $ 35,150 14,871 35,150 $ 19,597
Supplemental cash flow disclosures:            
Cash paid for interest         721  
Supplemental disclosure of non-cash financing activities:            
Conversion of convertible preferred stock into common stock         42,075  
Reclassification of convertible preferred stock warrant liability into additional paid-in capital $ 5,700       5,711  
Issuance of warrants in connection with the issuance of notes payable to a financial institution         111  
Deferred offering costs included in other assets       $ 66 $ 986  

Source